TrialJournal of the American College of Cardiology2021

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.

Milton Packer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.